Quote Spy AUXL NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.



Enter Tickers





   Auxilium Pharmaceuticals (AUXL)
 
Click the portfolio to add AUXL:
Close [X]
+ Add AUXL to Portfolio
Last Trade: 34.93 -0.07 (-0.20%) @ 4:00 PM

3-Month Chart (Larger chart w/volume)

Close [X]

1m  3m  6m  1y  2y 
Volume: 332,156 Avg Volume: 368,000
Day's Range: 34.68 - 35.22 52-wk Range: 17.96 - 37.28
Open: 35.01 Market Cap: 1.6B
Previous Close: 35.00 P/E: -27.6
Bid: 33.93 x 1 Div Yield: $0.00 (0.00%)
Ask: 35.10 x 1    
Spy AUXL
To see which Pros and tickerspy members own AUXL Sign up now
Indexes
None
Additional AUXL resources



Customize Links
Latest AUXL Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

To start a new thread post a Link or Note and tag it AUXL
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results and Operational Highlights
AUXL  
Linked by marketwire - October 28, 07:14AM from (www2.marketwire.com)
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced financial results and  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Auxilium Pharmaceuticals to Announce Third Quarter 2009 Results and Conduct Conference Call on Wednesday, October 28, 2009
AUXL  
Linked by marketwire - October 14, 07:00AM from (www2.marketwire.com)
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the third  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
U.S. Food and Drug Administration's Arthritis Advisory Committee Votes Unanimously 12-0 to Recommend Approval of XIAFLEX(TM) for Dupuytren's Contracture
AUXL  
Linked by marketwire - September 16, 03:46PM from (www2.marketwire.com)
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that the Arthritis  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Auxilium Pharmaceuticals "buy," target price raised
AUXL  
Linked by newratings - September 15, 01:13PM from (www.newratings.com)
NEW YORK, September 15 (newratings.com) - Analysts at Deutsche Bank Securities reiterate their "buy" rating on  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results and Operational Highlights
AUXL  
Linked by marketwire - August 06, 06:00AM from (www2.marketwire.com)
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced financial results and  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Auxilium Pharmaceuticals to Announce Second Quarter 2009 Results and Conduct Conference Call on Thursday, August 6, 2009
AUXL  
Linked by marketwire - July 23, 07:29AM from (www2.marketwire.com)
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the second  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Auxilium Pharmaceuticals initiated with "sell"
AUXL  
Linked by newratings - July 20, 01:43PM from (www.newratings.com)
NEW YORK, July 20 (newratings.com) - Analysts at Caris & Co initiate coverage of Auxilium Pharmaceuticals Inc (ticker:  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Auxilium Bullish Call Action
AUXL  
Posted by Options_Hawk - June 27, 09:56AM
Auxillium Pharma (AUXL) trades a 2,00 contract bullish risk reversal for $1.80, trader buying the September $35 calls, financed  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Auxilium Pharmaceuticals Selects Cegedim Dendrite SaaS CRM Solution
AUXL  
Linked by BusinessWire - June 18, 12:00PM from (www.businesswire.com)
Cegedim Dendrite today announced that Auxilium Pharmaceuticals (NASDAQ: AUXL) has selected and deployed the Software-as-a-Service  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5


 



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource